Keywords: sanofi, irbesartan, outperforms, losartan, sanofi/bristol-myers, squibb, angiotensin

Sanofi's Irbesartan Outperforms Losartan

Article | 25 November 1997

Sanofi/Bristol-Myers Squibb's angiotensin II receptor antagonistirbesartan is significantly more effective than Merck & Co's losartan in lowering blood pressure in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Merck

Merck KGaA

Go to company listing

Related Drugs

Avapro

irbesartan

Go to drug listing